↓ Skip to main content

Developments in the treatment of visceral leishmaniasis

Overview of attention for article published in Expert Opinion on Emerging Drugs, August 2009
Altmetric Badge

Mentioned by

wikipedia
2 Wikipedia pages

Citations

dimensions_citation
77 Dimensions

Readers on

mendeley
78 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Developments in the treatment of visceral leishmaniasis
Published in
Expert Opinion on Emerging Drugs, August 2009
DOI 10.1517/14728210903153862
Pubmed ID
Authors

Margriet Leontine den Boer, Jorge Alvar, Robert N Davidson, Koert Ritmeijer, Manica Balasegaram

Abstract

Visceral leishmaniasis (VL) is one of the most neglected parasitic diseases causing large scale mortality and morbidity among the poorest of the poor in the Indian subcontinent and Africa.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Bahrain 1 1%
Belgium 1 1%
Brazil 1 1%
Unknown 75 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 15 19%
Researcher 12 15%
Student > Master 10 13%
Student > Bachelor 9 12%
Other 5 6%
Other 13 17%
Unknown 14 18%
Readers by discipline Count As %
Medicine and Dentistry 24 31%
Agricultural and Biological Sciences 12 15%
Chemistry 6 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Immunology and Microbiology 4 5%
Other 11 14%
Unknown 17 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 April 2017.
All research outputs
#7,453,350
of 22,786,087 outputs
Outputs from Expert Opinion on Emerging Drugs
#174
of 493 outputs
Outputs of similar age
#32,049
of 90,489 outputs
Outputs of similar age from Expert Opinion on Emerging Drugs
#5
of 10 outputs
Altmetric has tracked 22,786,087 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 493 research outputs from this source. They receive a mean Attention Score of 4.2. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 90,489 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.